A Randomized Phase II Trial Evaluating the Performance of Genomic Expression Profiles to Direct the Use of Preoperative Chemotherapy for Early Stage Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Docetaxel; Doxorubicin
- Indications Early breast cancer
- Focus Pharmacogenomic; Therapeutic Use
Most Recent Events
- 11 Dec 2015 Biomarkers information updated
- 23 Jul 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 17 Feb 2010 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.